Prospective Study
Copyright ©The Author(s) 2018.
World J Crit Care Med. Feb 4, 2018; 7(1): 16-23
Published online Feb 4, 2018. doi: 10.5492/wjccm.v7.i1.16
Table 1 Demographics, symptoms, co-morbidities, and laboratory parameters in patients with and without myocarditis
CharacteristicWith myocarditis (n = 10)No myocarditis (n = 71)P value
Demographic
Age, mean (SD), yr56.5 (13.7)48.4 (16.2)0.14
Gender (female:male)41:30:005:050.64
Illness duration, mean (SD), d6.8 (3.1)8.3 (3.0)0.16
Symptom, n (%)
Fever10 (100)71 (100)1.00
Cough2 (10)27 (38)0.27
Breathlessness8 (80)54 (76)0.78
Altered mental status3 (30)12 (16.9)0.32
Myalgia5 (50)25 (35.2)0.36
Vomiting3 (30)19 (27.8)0.83
Co-morbidity, n (%)
Diabetes016 (22.5)0.09
Hypertension1 (10)14 (19.7)0.46
Pregnancy05 (7)0.39
Coronary artery disease02 (2.8)0.59
Smoking1 (10)2 (2.8)0.26
Laboratory parameter, mean (SD)
Hemoglobin, g %12.9 (3.6)11.3 (2.2)0.06
Total white cell count, cmm11360 (5484)10649.3 (4879)0.67
Platelets, cmm47400 (36039)65376 (62668)0.38
Creatinine, mg %1.6 (1.1)1.7 (1.5)0.76
Total bilirubin, mg %1.7 (1.1)2.1 (2.0)0.49
Direct bilirubin, mg %1.3 (1.0)1.6 (1.7)0.55
Serum albumin, mg %2.3 (0.7)2.6 (0.5)0.20
AST, U/L173 (143)142 (92)0.37
ALT, U/L69 (53)71.7 (51)0.88
Alkaline phosphatase, U/L196 (105)203 (108)0.84
SOFA score10.6 (2.8)8.7 (4.0)0.16
APACHE II score17.1 (8.3)15.5 (6.8)0.50
Table 2 Comparison of cardiac parameters in patients with and without myocarditis
ParameterWith myocarditis (n = 10)No myocarditis (n = 71)P value
Electrocardiography finding, n (%)
Sinus tachycardia3 (30)35 (49.3)0.25
ST-T changes2 (20)8 (11.3)0.43
T wave inversion3 (30)5 (7)0.0231
QRS morphology changes5 (50)6 (8.5)< 0.0011
Supraventricular tachycardia01 (1.4)0.70
Atrial fibrillation03 (4.2)0.51
Wide QRS tachycardia01 (1.4)0.71
Sinus bradyarrhythmia1 (10)4 (5.6)0.59
Cardiac biomarker, mean (SD)
CK-MB (ng/mL)14.1 (18.1)5.9 (7.1)0.0091
Troponin T (pg/mL)235.9 (475.2)61.6 (136.5)0.0141
Echocardiography finding, mean (SD)
LVEF41.6 (8.8)59.8 (13.3)< 0.0011
Cardiac index2.7 (1.1)2.6 (0.9)0.79
Systemic vascular resistance2417 (1280)2354 (891)0.85
E/A0.9 (0.2)1.2 (0.4)0.06
E/e’9.9 (4.0)9.8 (3.4)0.94
CVP, cm13.5 (5.3)10.9±5.20.15
Table 3 Outcomes in patients with and without myocarditis in scrub typhus infection
CharacteristicWith myocarditis (n = 10)No myocarditis (n = 71)P value
Outcome variable, n (%)
Needing ventilation7 (70)41 (57.7)0.46
Non-invasive ventilation3 (30)12 (16.9)0.32
Invasive ventilation5 (50)34 (47.9)0.90
Duration of ICU stay, mean (SD), d5.0 (4.8)4.0 (4.4)0.53
Length of hospital stay, mean (SD), d11.6 (5.7)8.9 (4.5)0.10
Needing dialysis1 (10)2 (2.8)0.26
Needing vasoactive agent9 (90)37 (52.1)0.0241
Mortality1 (10)7 (9.9)0.99
Table 4 Bivariate and multivariate logistic regression analyses of factors associated with myocarditis in scrub typhus infection
VariableBivariate analysis
Multivariate analysis
OR (95%CI)P valueOR (95%CI)P value
Age1.03 (0.99-1.08)0.141.04 (0.99-1.09)0.08
Gender0.73 (0.19-2.76)0.64
Symptom duration0.84 (0.65-1.07)0.160.69 (0.49-0.98)0.04
APACHE-II score1.03 (0.94-1.13)0.49
SOFA score1.13 (0.95-1.34)0.161.12 (0.89-1.41)0.32
Need for ventilation1.71 (0.41-7.15)0.46
Hospital length of stay1.11 (0.98-1.27)0.101.17 (0.98-1.40)0.09
Mortality1.02 (0.11-9.25)0.99